BSE Live
Dec 26, 16:01Prev. Close
1737.50
Open Price
1727.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:54Prev. Close
1737.00
Open Price
1737.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1719.50 (503)
| Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 949.16 | 1,295.40 | 1,052.20 | 640.54 | 488.68 | |
| Net CashFlow From Operating Activities | 658.12 | 1,262.49 | 626.13 | 444.25 | 310.83 | |
| Net Cash Used In Investing Activities | -170.88 | -660.37 | -743.49 | -112.07 | 160.76 | |
| Net Cash Used From Financing Activities | -327.34 | -325.67 | -6.06 | -360.48 | -130.80 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 159.90 | 276.45 | -123.42 | -28.30 | 340.79 | |
| Cash And Cash Equivalents Begin of Year | 48.00 | 977.31 | 1,208.48 | 1,230.98 | 890.03 | |
| Cash And Cash Equivalents End Of Year | 207.90 | 1,253.76 | 1,085.06 | 1,202.68 | 1,230.82 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend